Walk in interview for Ph.D, B.Pharm, M.Sc to work in research at IICT | 08 posts
Indian Institute of Chemical Technology, Hyderabad is a premier R&D Institute in India. The Institute had its origin as the Central Laboratories for Scientific & Industrial Research (CLSIR), established in 1944 by the then Government of Hyderabad State. After integration of Hyderabad State with the Indian Union, the laboratory expanded with its growing activities. The main building was formally opened by Pandit Jawaharlal Nehru, the then Prime Minister of India on January 2, 1954. In 1956, the Central Laboratories came under the aegis of the Council of Scientific & Industrial Research (CSIR), New Delhi and was renamed Regional Research Laboratory, Hyderabad (RRL-H).
CSIR – IICT is conducting Walk-in Interview for the following positions purely on a temporary basis for various projects CSIR-IICT, Hyderabad
Pondicherry University is outstanding among the Central Universities in India. Teaching and research are its primary functions as in other Central Universities. In addition, it has also affiliated colleges located in Puducherry, Karaikal, Mahe, Yanam and the Union Territory of Andaman & Nicobar Islands. The Union Territory of Lakshadweep is also expected to have a college affiliated to Pondicherry University in the near future.
Indian Institute of Technology Delhi is one of the seven Institutes of Technology created as centres of excellence for higher training, research and development in science, engineering and technology in India, the others being at Kanpur, Kharagpur, Madras, Bombay, Guwahati and Roorkee. Established as College of Engineering in 1961, the Institute was later declared an Institution of National Importance under the "Institutes of Technology (Amendment) Act, 1963" and was renamed "Indian Institute of Technology Delhi". It was then accorded the status of a deemed university with powers to decide its own academic policy, to conduct its own examinations, and to award its own degrees.
NIPER Ahmedabad was initiated with three specializations Biotechnology, Natural Products and Pharmaceutics and over the period of time three more specialisations Pharmaceutical Analysis, Medicinal Chemistry and Pharmacology and Toxicology were added in 2010. Subsequently in 2011, to cater the needs of Medical device industry in India, another feather was added to the cap of NIPER Ahmedabad in the form of specialisation in Medical Devices.
A primary objective of the Institute is to train and nurture human resources in the Sciences for the knowledge economies of the future. This is in line with a general shift in geo-political thinking that requires a remedy for sites of knowledge production centred in the west. Such a strategic shift in perspective has been necessitated by the realization that the unique circumstances of our nation demand unique scientific and pedagogic responses. Consequently, we are called upon to question and account for conventional narratives that stake claims to categorizations of science, technology, environment, learning, innovation, design and being. The predominant discourse that seeks to structure these superficially hard categories is predicated on justifications that till date have not moved beyond regimes of hierarchy, control and access. These strictures are an inherent feature of “Institutionalized Science” where Newtonian principles of organizing domains of cognition and mechanisms of representation constrain debates on what new conceptualizations of science ought to be like. More problematically this stifles the potential for interdisciplinarity just when everybody talks its language.
Piramal Enterprises Ltd. provides a world class integrated drug discovery services platform from our state-of-the-art research Centre in India. PDS's delivery model has a proven track record of providing a step change in the effectiveness of drug discovery for a range of global pharmaceuticals and biotechnology companies operating at the forefront of drug discovery. PDS understands that early and intensive evaluation of the molecules based on thorough communications and rapid decision-making will lead to a high throughput of successful drug-like compounds.
